These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38087641)

  • 1. Preparation of Piroxicam nanosuspensions by high pressure homogenization and evaluation of improved bioavailability.
    Aksoy OA; Zanbak Çotaoğlu M; Fatsa T; Topal GR; Eşim Ö; Göksel BA; Hoşbul T; Özkan CK; Savaşer A; Özkan Y
    Drug Dev Ind Pharm; 2023 Dec; 49(12):715-722. PubMed ID: 38087641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3
    Alhamhoom Y; Honmane SM; Hani U; Osmani RAM; Kandasamy G; Vasudevan R; Paramshetti S; R Dudhal R; K Kengar N; Charde MS
    Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
    Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
    Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo Evaluation of Ibuprofen Nanosuspensions for Enhanced Oral Bioavailability.
    Hedaya M; Bandarkar F; Nada A
    Med Princ Pract; 2021; 30(4):361-368. PubMed ID: 33823524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
    Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
    J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
    Zawar LR; Bari SB
    Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and pharmacokinetics of cyadox nanosuspension.
    Sattar A; Chen D; Jiang L; Pan Y; Tao Y; Huang L; Liu Z; Xie S; Yuan Z
    Sci Rep; 2017 May; 7(1):2289. PubMed ID: 28536446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose-sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin.
    Xie J; Luo Y; Liu Y; Ma Y; Yue P; Yang M
    Int J Nanomedicine; 2019; 14():353-369. PubMed ID: 30655668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
    Gera S; Talluri S; Rangaraj N; Sampathi S
    AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Oral Bioavailability of Lacidipine Using Nanosuspension Technology: Inferior in vitro Dissolution and Superior in vivo Drug Absorption versus Lacipil®.
    Zhao J; Luo L; Fu Q; Guo B; Li Y; Geng Y; Wang J; Zhang T
    Curr Drug Deliv; 2016; 13(5):764-73. PubMed ID: 25963306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production, Characterization and Evaluation of Kaempferol Nanosuspension for Improving Oral Bioavailability.
    Qian YS; Ramamurthy S; Candasamy M; Shadab M; Kumar RH; Meka VS
    Curr Pharm Biotechnol; 2016; 17(6):549-55. PubMed ID: 26813303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.